These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1194 related articles for article (PubMed ID: 18058481)
1. Blood pressure and serum potassium levels in hypertensive patients receiving or not receiving antihypertensive treatment. Pikilidou MI; Lasaridis AN; Sarafidis PA; Tziolas IM; Zebekakis PE; Dombros NV; Giannoulis E Clin Exp Hypertens; 2007 Nov; 29(8):563-73. PubMed ID: 18058481 [TBL] [Abstract][Full Text] [Related]
2. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment]. Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399 [TBL] [Abstract][Full Text] [Related]
3. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug. Ohta Y; Tsuchihashi T; Onaka U; Eto K; Ueno M Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208 [TBL] [Abstract][Full Text] [Related]
4. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs. Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973 [TBL] [Abstract][Full Text] [Related]
5. Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management. Petrella R; Michailidis P Clin Ther; 2011 Sep; 33(9):1190-203. PubMed ID: 21885126 [TBL] [Abstract][Full Text] [Related]
6. Higher small arterial elasticity in hypertensive patients treated with angiotensin II receptor blockers. Takeuchi K; Ideishi M; Tashiro T; Morishige N; Yamada T; Saku K; Urata H Hypertens Res; 2005 Aug; 28(8):639-44. PubMed ID: 16392767 [TBL] [Abstract][Full Text] [Related]
7. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy. Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C; Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142 [TBL] [Abstract][Full Text] [Related]
8. Current status of antihypertensive prescription and associated blood pressure control in Japan. Mori H; Ukai H; Yamamoto H; Saitou S; Hirao K; Yamauchi M; Umemura S Hypertens Res; 2006 Mar; 29(3):143-51. PubMed ID: 16755149 [TBL] [Abstract][Full Text] [Related]
11. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study. Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367 [TBL] [Abstract][Full Text] [Related]
12. White coat effect in treated and untreated patients with high office blood pressure. Relationship with pulse wave velocity and left ventricular mass index. Silveira A; Mesquita A; Maldonado J; Silva JA; Polónia J Rev Port Cardiol; 2002 May; 21(5):517-30. PubMed ID: 12174516 [TBL] [Abstract][Full Text] [Related]
13. Differential impact of angiotensin receptor blockers and calcium channel blockers on arterial stiffness. Andreadis EA; Sfakianakis ME; Tsourous GI; Georgiopoulos DX; Fragouli EG; Katsanou PM; Tavoularis EI; Skarlatou MG; Marakomichelakis GE; Ifanti GK; Diamantopoulos EJ Int Angiol; 2010 Jun; 29(3):266-72. PubMed ID: 20502415 [TBL] [Abstract][Full Text] [Related]
14. Alpha 1-blockade for the treatment of hypertension: a megastudy of terazosin in 2214 clinical practice settings. Itskovitz HD Clin Ther; 1994; 16(3):490-504. PubMed ID: 7923316 [TBL] [Abstract][Full Text] [Related]
15. Prevalence and management of hypertension in primary care in Portugal. Insights from the VALSIM study. Cortez-Dias N; Martins S; Belo A; Fiuza M; Rev Port Cardiol; 2009 May; 28(5):499-523. PubMed ID: 19650569 [TBL] [Abstract][Full Text] [Related]
16. [Inadequate treatment and control of arterial hypertension in patients with type 2 diabetes mellitus]. Boero R; Prodi E; Borsa S; Berti V; Fiorio E; Ferraro L; Massara C; Quarello F G Ital Nefrol; 2002; 19(4):413-8. PubMed ID: 12369043 [TBL] [Abstract][Full Text] [Related]
17. Antihypertensive effect of oral potassium aspartate supplementation in mild to moderate arterial hypertension. Franzoni F; Santoro G; Carpi A; Da Prato F; Bartolomucci F; Femia FR; Prattichizzo F; Galetta F Biomed Pharmacother; 2005; 59(1-2):25-9. PubMed ID: 15740932 [TBL] [Abstract][Full Text] [Related]
18. The quality of arterial hypertension treatment in cardiology service in Kosovo--a single center study. Bajraktari G; Sylejmani X; Thaçi K; Elezi S; Ndrepepa G Anadolu Kardiyol Derg; 2009 Apr; 9(2):96-101. PubMed ID: 19357050 [TBL] [Abstract][Full Text] [Related]
19. The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy. Khan NA; McAlister FA; Lewanczuk RZ; Touyz RM; Padwal R; Rabkin SW; Leiter LA; Lebel M; Herbert C; Schiffrin EL; Herman RJ; Hamet P; Fodor G; Carruthers G; Culleton B; DeChamplain J; Pylypchuk G; Logan AG; Gledhill N; Petrella R; Campbell NR; Arnold M; Moe G; Hill MD; Jones C; Larochelle P; Ogilvie RI; Tobe S; Houlden R; Burgess E; Feldman RD; Can J Cardiol; 2005 Jun; 21(8):657-72. PubMed ID: 16003449 [TBL] [Abstract][Full Text] [Related]
20. Treating hypertension by rational use of diuretics: results of the Russian ARGUS-2 Study. Kobalava ZD; Kotovskaya YV; Villevalde SV; Moiseev VS; Curr Med Res Opin; 2009 Sep; 25(9):2229-37. PubMed ID: 19622008 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]